Which scenario warrants referral to a nephrologist?

Which scenario warrants referral to a nephrologist?

• A. eGFR decline greater than 5 mL/min/1.73 m2 per year
• B. Known diabetic nephropathy with stable eGFR
• C. Stage 2 CKD with eGFR 70
• D. CKD of unknown etiology with rapid deterioration

Answer: (D)

When should you involve nephrology? The strongest trigger is rapid kidney function loss with an unclear cause. If CKD is progressing quickly and you don’t know why, you need a specialist to determine the underlying process—often requiring targeted tests, serologies, imaging, and sometimes a kidney biopsy—to confirm a potentially treatable or reversible condition (for example, glomerulonephritis or other active kidney diseases) and to guide urgent management and planning for dialysis or transplant if needed. Early nephrology input can prevent irreversible damage. In the other scenarios, the picture is more stable or straightforward. Known diabetic nephropathy with a stable eGFR can be managed in primary care with optimized blood pressure control, RAAS blockade, glycemic control, and regular monitoring. Stage 2 CKD with an eGFR around 70 is early CKD and typically managed with risk-factor modification and surveillance rather than urgent specialty referral. An eGFR decline greater than 5 mL/min/year is concerning and requires close follow-up, but without an unknown etiology, the situation may be managed with careful monitoring and PCP coordination unless progression accelerates or red flags appear.

When should you involve nephrology? The strongest trigger is rapid kidney function loss with an unclear cause. If CKD is progressing quickly and you don’t know why, you need a specialist to determine the underlying process—often requiring targeted tests, serologies, imaging, and sometimes a kidney biopsy—to confirm a potentially treatable or reversible condition (for example, glomerulonephritis or other active kidney diseases) and to guide urgent management and planning for dialysis or transplant if needed. Early nephrology input can prevent irreversible damage.

In the other scenarios, the picture is more stable or straightforward. Known diabetic nephropathy with a stable eGFR can be managed in primary care with optimized blood pressure control, RAAS blockade, glycemic control, and regular monitoring. Stage 2 CKD with an eGFR around 70 is early CKD and typically managed with risk-factor modification and surveillance rather than urgent specialty referral. An eGFR decline greater than 5 mL/min/year is concerning and requires close follow-up, but without an unknown etiology, the situation may be managed with careful monitoring and PCP coordination unless progression accelerates or red flags appear.